NASDAQ:SMTI Sanara MedTech Q2 2026 Earnings Results & Report $35.13 -0.02 (-0.06%) As of 10/13/2026 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more. Sanara MedTech missed analyst expectations on both earnings and revenue in its Q2 2026 results, released August 11, 2026. The company reported EPS of -$0.05 versus the -$0.0250 consensus estimate, while revenue of $28.14 million fell short of the $28.95 million estimate by $0.81 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 11, 2026TimeAfter Market ClosesConference Call4:00 PM ET Sanara MedTech EPS ResultsActual EPS-$0.05Consensus EPS -$0.0250Beat/MissMissed by -$0.0250One Year Ago EPSN/AEPS Beat Rate4 of last 7 quartersSanara MedTech Revenue ResultsActual Revenue$28.14 millionExpected Revenue$28.95 millionBeat/MissMissed by -$813.24 thousandYoY Revenue GrowthN/AUpcoming EarningsSanara MedTech's Q3 2026 earnings is estimated for Wednesday, November 11, 2026, based on past reporting schedules, with a conference call scheduled on Monday, November 9, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Sanara MedTech Q2 2026 Earnings FAQ Did Sanara MedTech beat earnings estimates for Q2 2026? Sanara MedTech (NASDAQ:SMTI) reported earnings of -$0.05 per share for Q2 2026, missing the consensus estimate of -$0.0250. The report was announced on Tuesday, August 11, 2026. What was Sanara MedTech's revenue for Q2 2026? Sanara MedTech reported revenue of $28.14 million for Q2 2026, against a consensus estimate of $28.95 million. When is Sanara MedTech's next earnings date? Sanara MedTech's next earnings date is estimated for Wednesday, November 11, 2026. MarketBeat tracks confirmed and estimated earnings dates for Sanara MedTech on the company's earnings history page. Sanara MedTech Earnings HeadlinesHead-To-Head Comparison: Kewaunee Scientific (NASDAQ:KEQU) versus Sanara MedTech (NASDAQ:SMTI)October 6, 2026 | americanbankingnews.comComparing Profound Medical (NASDAQ:PROF) and Sanara MedTech (NASDAQ:SMTI)October 6, 2026 | americanbankingnews.comDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December. | Porter & Company (Ad)Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTISeptember 10, 2026 | businesswire.comSMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its ShareholdersAugust 29, 2026 | businesswire.comSanara MedTech IncAugust 14, 2026 | money.usnews.comSee More Sanara MedTech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sanara MedTech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sanara MedTech and other key companies, straight to your email. Email Address About Sanara MedTechSanara MedTech (NASDAQ:SMTI) is a medical technology company focused on developing, commercializing and distributing products designed to support surgical procedures and the management of complex wounds. Its offerings are intended for use by hospitals, surgical centers, wound-care providers and other healthcare professionals. The company’s portfolio includes advanced wound-care technologies such as CellerateRX® products, which are collagen-based products used to support the healing process, and BIAKŌS® antimicrobial wound-care products. Sanara also offers products and technologies serving areas such as tissue management, wound cleansing, infection prevention and negative-pressure wound therapy. Sanara MedTech primarily serves the U.S. healthcare market through commercial and distribution relationships with healthcare providers and facilities. The company has expanded its product portfolio through product development, strategic transactions and partnerships, with a focus on addressing the needs of patients with chronic, surgical and hard-to-heal wounds.View Sanara MedTech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow RunwayJPMorgan Earnings Miss Estimates But Reveal Broad-Based StrengthAmazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?A Silent Winner: Texas Instruments Anchors the AI SupercycleDelta's Guidance Cut Could Spell Trouble for the Airline Industry5 Retail Picks to Watch as the Holiday Shopping Season Nears Upcoming Earnings Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026)Fastenal (10/14/2026)ASML (10/14/2026)Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
